<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

LSX: THE COMMUNITY FOR LIFE SCIENCE EXECUTIVES

LSX, formerly Biotech and Money, is an influential community of senior life science decision makers. We connect senior life science executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses. We achieve this through a programme of high-level conferences and networking events, via content that showcases and shares the expertise of investors, senior leaders and industry stakeholders, as well as through bespoke initiatives.

Upcoming Events
Blog and Content
Our Community

OUR CONFERENCE AND COMMUNITY BRANDS

LSX World Congress.png
Investival Header.png
LSX Nordic Congress-1.png
LSX World Congress USA
LSX CEO Forum
LSX Connect
LSX Investor Club

INVESTMENT AND IPOS

Investorview: Propelling life science innovation from pre-seed to patients

Denmark’s Novo Seeds was established in 2007 in order to identify promising...

Read More

Gates Foundation funding for DelSiTech’s silica-based drug delivery technology

Key learnings: DelSiTech has been awarded significant grant funding from th...

Read More

Lifestars Awards 2018 celebrate life science successes

LSX (formerly Biotech and Money) hosted the Lifestars Awards at the Honoura...

Read More
View More

M&A AND DEAL MAKING

Medius Deal Watch: September-October 2018

There was much speculation last year that the US tax cuts that favoured the...

Read More

Lifestars Awards 2018 celebrate life science successes

LSX (formerly Biotech and Money) hosted the Lifestars Awards at the Honoura...

Read More

M&A deals and the pharmaceutical sector: Are your IP ducks in a row?

2018 has so far been a productive year for M&A deals in the pharmaceutical ...

Read More
View More

R&D TO COMMERCIALISATION

World-first accreditation to out-of-this-world applications for Oxehealth’s vital signs technology

Key learnings: Oxford-based Oxehealth has secured medical device accreditat...

Read More

Gates Foundation funding for DelSiTech’s silica-based drug delivery technology

Key learnings: DelSiTech has been awarded significant grant funding from th...

Read More

Lifestars Awards 2018 celebrate life science successes

LSX (formerly Biotech and Money) hosted the Lifestars Awards at the Honoura...

Read More
View More

IP, REGULATION AND COMPLIANCE

Vital signs in UK life sciences

In 2017, Professor Sir John Bell published the well-received Life Sciences ...

Read More

AI update: medical software and pre-emption

In light of the rapidly expanding field of medical software technology, and...

Read More
View More

TALENT AND EXECUTIVE STRATEGY

Investorview: Propelling life science innovation from pre-seed to patients

Denmark’s Novo Seeds was established in 2007 in order to identify promising...

Read More

Lifestars Awards 2018 celebrate life science successes

LSX (formerly Biotech and Money) hosted the Lifestars Awards at the Honoura...

Read More

Bolstering women in the C-suite and boardroom

The leadership landscape within life sciences is beginning to change. More ...

Read More
View More

COMMUNITY PARTNERS AND PREMIUM COMMUNITY MEMBERS

Alacrita
allen and overy-022869-edited.png
Appleyard Lees
barclays
Cancer Research UK.jpg
CMS Cameron Mckenna.png
covington.png
Dyadic.png
gje.png
Gallagher.png
Horizon Logo-581398-edited.png
illumina-logo.svg
Inceptua
Marks and Clerk-1-970684-edited.png
Storm Therapeutics.png
Xplico-3-758243-edited.png